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ABSTRACT Clustered,regularlyinterspacedshortpalindromicrepeats(CRISPR)providebacteriaandarchaeawithsequence-
speciﬁc,acquireddefenseagainstplasmidsandphage.Becausemobileelementsconstituteupto25%ofthegenomeof
multidrug-resistant(MDR)enterococci,itwasofinteresttoexaminethecodistributionofCRISPRandacquiredantibioticresis-
tance in enterococcal lineages. A database was built from 16 Enterococcus faecalis draft genome sequences to identify commonal-
itiesandpolymorphismsinthelocationandcontentofCRISPRloci.Withthisdataset,wewereabletodetectidentitiesbetween
CRISPRspacersandsequencesfrommobileelements,includingpheromone-responsiveplasmidsandphage,suggestingthat
CRISPR regulates the ﬂux of these elements through the E. faecalis species. Based on conserved locations of CRISPR and
CRISPR-caslociandthediscoveryofanewCRISPRlocuswithassociatedfunctionalgenes,CRISPR3-cas,wescreenedadditional
E. faecalis strains for CRISPR content, including isolates predating the use of antibiotics. We found a highly signiﬁcant inverse
correlation between the presence of a CRISPR-cas locus and acquired antibiotic resistance in E. faecalis, and examination of an
additional eight E. faecium genomes yielded similar results for that species. A mechanism for CRISPR-cas loss in E. faecalis was
identiﬁed.TheinverserelationshipbetweenCRISPR-casandantibioticresistancesuggeststhatantibioticuseinadvertentlyse-
lectsforenterococcalstrainswithcompromisedgenomedefense.
IMPORTANCE Formanybacteria,includingtheopportunisticallypathogenicenterococci,antibioticresistanceismediatedby
acquisitionofnewDNAandisfrequentlyencodedonmobileDNAelementssuchasplasmidsandtransposons.Certainentero-
coccallineageshaverecentlyemergedthatarecharacterizedbyabundantmobileDNA,includingnumerousviruses(phage),and
plasmidsandtransposonsencodingmultipleantibioticresistances.Theselineagescausehospitalinfectionoutbreaksaroundthe
world.ThestrikinginﬂuxofmobileDNAintotheselineagesisincontrasttowhatwouldbeexpectedifaself(genome)-defense
systemwaspresent.Clustered,regularlyinterspacedshortpalindromicrepeat(CRISPR)defenseisarecentlydiscoveredmecha-
nismofprokaryoticself-defensethatprovidesatypeofacquiredimmunity.Here,weﬁndthatantibioticresistanceandposses-
sionofcompleteCRISPRlociareinverselyrelatedandthatmembersofrecentlyemergedhigh-riskenterococcallineageslack
completeCRISPRloci.Ourresultssuggestthatantibiotictherapyinadvertentlyselectsforenterococciwithcompromisedge-
nomedefense.
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E
nterococcus faecalis and Enterococcus faecium rank among the
leading causes of antibiotic-resistant hospital-acquired bacterial
infections (1–3). Resistance to last-line drugs, such as vancomycin
(4), is common, and enterococci are now disseminating this resis-
tance to methicillin-resistant Staphylococcus aureus (MRSA) (5–7).
The ﬁrst vancomycin-resistant E. faecalis isolate in the United States,
V583 (8), is a member of clonal complex 2 (CC2) (9), a cluster of
hospital-adapted lineages that emerged as early as 1981 (10). It was
theﬁrstEnterococcusisolateforwhichagenomesequencewasdeter-
mined (11). Mobile elements constitute one-quarter of its genome
andincludethreeindependentlyreplicatingplasmids,threechromo-
somally integrated plasmid remnants, seven prophage, and a patho-
genicityisland(PAI)(11,12).TheE.faeciumhospital-adaptedlin-
eage CC17 (13), which emerged as early as 1982 (14), is similarly
characterized by an abundance of exogenously acquired genes,
including insertion sequences, phage, and antibiotic resistance
genes (15).
Enterococci are natural inhabitants of the digestive tracts of
humansandothermammals(16).Genomeanalysisofthenatively
antibiotic-sensitive human oral isolate of E. faecalis, OG1RF, re-
vealed that this strain lacks most of the mobile elements and ex-
ternally acquired DNA found in the hospital-adapted strain V583
(17). Instead, two clustered, regularly interspaced short palin-
dromic repeat (CRISPR) loci were identiﬁed (17). CRISPR is a
prokaryotic sequence-speciﬁc defense system that provides a type
of acquired immunity (18, 19). Mechanistic details are emerging,
but in general, a small segment of an invading mobile element is
incorporatedintotheCRISPRarraybetweenroughlypalindromic
repeats (20, 21). This mobile element segment is then transcribed
andprocessedatthepalindromestogenerateasmallRNAtermed
crRNA (22). crRNA targets CRISPR-associated nucleases, en-
coded by the CRISPR-associated genes (cas genes), to incoming
mobile elements from which the spacers derive (20, 22, 23).
CRISPR defense appears to be widespread in prokaryotes, with
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vincing CRISPR loci (24). Of the two CRISPR loci discovered in
the E. faecalis OG1RF genome, one possesses the associated cas
nuclease genes (CRISPR1-cas) and one is an orphan locus lacking
cas genes (CRISPR2) (17). The hospital-adapted V583 strain pos-
sesses only the orphan locus CRISPR2, lacking the functional cas
genes required for CRISPR defense (25).
Because of the potential for limiting entry of mobile elements,
itwasofinteresttodeterminewhetheracorrelationexistsbetween
the presence of CRISPR loci and the emergence of antibiotic-
resistant enterococcal lineages. By examining enterococcal draft
genomes to develop consensus information on the occurrence of
CRISPR loci, and expanding the study to a historical collection of
isolatesthatextendscoveragethroughantibioticandpreantibiotic
eras, we found a strong correlation between the absence of
CRISPR-cas loci and the emergence of MDR enterococcal strains.
We hypothesize that widespread antibiotic use has selected for
enterococcal strains able to readily acquire novel traits—those
with compromised genome defense—ultimately leading to the
emergence of enterococcal lineages replete with antibiotic resis-
tances and other mobile traits.
RESULTS
CRISPR distribution in 16 E. faecalis draft genomes. We re-
cently collaborated in an effort to sequence the genomes of 28
enterococci,including16E.faecalisstrainsrepresentingdeepphy-
logenetic nodes in the E. faecalis multilocus sequence typing
(MLST) dendrogram (26). CRISPRﬁnder (27) was used to iden-
tify putative CRISPR loci in the 16 draft E. faecalis genomes. The
orphan CRISPR2 locus, consisting only of palindromes and spac-
ers, and not cas genes, was identiﬁed in all 16 E. faecalis genomes
and was invariably located between homologues of E. faecalis
V583 open reading frames (ORFs) EF2063 and EF2061 (Fig. 1).
CRISPR2repeatpalindromeswerehighlyconserved,ineverycase
being nearly or perfectly identical to the E. faecalis OG1RF
CRISPR1/2 repeat sequence (see Table S1 in the supplemental
material). In contrast, the occurrence of the CRISPR1-cas locus
varied (Fig. 1). Of the 16 genome sequences analyzed, 5 (ATCC
FIG1 CRISPR loci in E. faecalis draft genomes. Strains are organized by date of isolation, from oldest to most recent. Homologues of E. faecalis V583 genes are
shown as grey arrows and with V583 ORF assignments. CRISPR locus-speciﬁc genes are shown as white arrows, and CRISPR spacers are represented by black
diamonds. CRISPR spacers with identity to mobile elements are starred. Note that CRISPR repeats are not shown. Red rectangles denote deletions in the X98,
E1Sol, and DS5 CRISPR1-cas loci. An “X” denotes a frameshift mutation in the D6 CRISPR1-cas region corresponding to OG1RF_0022. The E. faecalis V583
CRISPR2 locus and the OG1RF CRISPR1-cas and CRISPR2 loci were previously reported (17, 25). Red bars and text denote novel DNA sequences present in
V583. Primer sets used in CRISPR proﬁling are labeled with uppercase letters: A, CRISPR1-cas ﬂanking primers; B, CRISPR1-cas csn1 screening primers; C,
CRISPR2 screening primers; D, CRISPR3-cas ﬂanking primers; E, CRISPR3-cas csn1 screening primers. The ﬁgure is not drawn to scale.
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ways located between homologues of the V583 ORFs EF0672 and
EF0673 (Fig. 1).
TheputativeCasproteinsencodedbytheselociarehighlycon-
served,asarethepalindromicrepeatsequences(seeTablesS1and
S2 in the supplemental material). As for E. faecalis OG1RF
CRISPR1-cas, these loci are of the Nmeni subtype, a CRISPR-cas
organizationalstructurefoundonlyinvertebrate-associatedcom-
mensals and pathogens (28). OG1RF CRISPR1-cas includes an
ORF 3= to the CRISPR1 repeat-spacer array, OG1RF_0022, that
hasnohomologue(17)andisnotcommontoNmenisubtypeloci
(28).ThisORFvariesamongstrainswithCRISPR1-cas,withDS5,
E1Sol, and X98 possessing a 435-bp deletion extending 255 bp
into it (Fig. 1). A frameshift occurs in the homologue of
OG1RF_0022 in strain D6 (Fig. 1). Given the variability in this
region, this ORF may be dispensable for CRISPR function.
A novel CRISPR locus, CRISPR3-cas, was identiﬁed in the ge-
nomes of strains Fly1 and T11, occurring between homologues of
the E. faecalis V583 ORFs EF1760 and EF1759 (Fig. 1). CRISPR3-
cas also exhibits an organization consistent with Nmeni subtype
CRISPR loci (28) (see Table S3 in the supplemental material).
However, CRISPR3-cas is distinct from CRISPR1-cas and
CRISPR2 in palindrome repeat sequence (see Fig. S1 in the sup-
plemental material) and is distinct from CRISPR1-cas in cas gene
content.NmenisubtypelocipossesstheuniversalCRISPRmarker
gene cas1, the core CRISPR gene cas2, and the Nmeni subtype-
speciﬁcgenecsn1,whilepossessionoftheNmenisubtype-speciﬁc
gene csn2 varies (28). CRISPR1-cas possesses csn2, the fourth and
ﬁnal ORF in the inferred cas operon (17) (Fig. 1). Curiously, the
fourth ORF in the inferred E. faecalis T11 CRISPR3-cas operon
(Fig.1)doesnotencodeaproteinwithsigniﬁcantidentitytoCsn2
(TIGR01866) (28) or to any other conserved protein domains
(Table S3). In Fly1, the region corresponding to this unknown
ORF is interrupted by a frameshift mutation that results in two
truncated ORFs (Fig. 1).
CRISPR spacer identities with mobile elements. No identity
wasreportedbetweenE.faecalisOG1RFCRISPRspacersequences
and known mobile element sequences, or any other sequences
deposited in GenBank (17), and thus no evidence supporting a
role for CRISPR in E. faecalis self-defense exists. Having a larger
data set of 140 CRISPR spacers from 16 additional genomes, we
queried the NCBI nonredundant nucleotide database to identify
elements with possible identity to E. faecalis CRISPR spacer se-
quences. Because spacer sequences are small (30 bp), only hits
with90%identity(27of30nucleotides)wereconsideredsignif-
icant. By this criterion, identities to 38 of 140 E. faecalis CRISPR
spacers were found. Of the 38 hits, 19 were identical to CRISPR2
spacers of the previously sequenced E. faecalis OG1RF and V583
genomes and 19 were derived from mobile elements (Table 1).
These elements include the pheromone-responsive type plasmids
pAD1/pTEF1 and pCF10/pTEF2, enterococcal phage and pro-
phage,andplasmidsintegratedwithintheE.faecalisV583genome
(Table 1). Identities to certain mobile elements were more com-
mon than others: ﬁve strains (ATCC4200, D6, T8, Fly1, and T11)
possess spacers with identity to pheromone-responsive plasmids,
andﬁvestrains(ATCC4200,D6,T8,Fly1,andARO1/DG)possess
spacer sequences with identities to different regions of E. faecalis
V583 prophage 6.
E. faecalis CRISPR-cas and acquired antibiotic resistance.
Examining the entire genomes of 16 E. faecalis strains allowed us
TABLE 1 E. faecalis CRISPR spacer identities to mobile genetic elements
Strain
CRISPR and
spacer no.a
Sequence
identityb
Representative
Blastn hit
Area of identity
in Blastn hit
Identical
Blastn hits
ATCC 4200 1-4 29/30 Enterococcus phage EF24C EFP_gp114 hypothetical protein
2-4 29/30 V583 prophage 6c EF2813 tail tape measure protein
2-5 30/30 V583 prophage 6 EF2836_EF2387 intergenic region
2-6 29/30 V583 pTEF2 EF_B0043 ssb-6 E. faecalis pCF10
29/30 E. faecalis pMG2200 ORF54 hypothetical protein BAH02364.1 E. faecalis pBEE99; pYI14
DS5 1-3 30/30 Enterococcus phage FL2B gp34-gp35 intergenic region Enterococcus phage FL2A
29/30 Enterococcus phage FL3B gp37-gp38 intergenic region Enterococcus phage FL3A; Ef11
28/30 Enterococcus phage FL1C gp39-gp40 intergenic region Enterococcus phage FL1B; FL1A
D6 1-8 29/30 V583 VR1c-integrated plasmid EF0133-EF0134 intergenic region
29/30 V583 VR11-integrated plasmid EF2539-EF2540 intergenic region
D6 2-1 29/30 V583 prophage 3 EF1486 endolysin
D6 2-2 29/30 V583 prophage 6 EF2834 hypothetical protein
D6 2-5 30/30 V583 pTEF2 EF_B0047 membrane protein, putative E. faecalis pCF10
T1 2-5 27/30 Enterococcus phage EF24C EFP_gp116 hypothetical protein
E1Sol 2-2 30/30 V583 VR11-integrated plasmid EF2535 nucleotidyltransferase domain protein
CH188 2-1 28/30 V583 prophage 1 EF0334 portal protein Enterococcus phage FL4A
T8d 2-3 30/30 V583 prophage 6 EF2836-EF2387 intergenic region
T8e 2-4 29/30 V583 pTEF2 EF_B0043 ssb-6 E. faecalis pCF10
29/30 E. faecalis pMG2200 ORF54 hypothetical protein BAH02364.1 E. faecalis pBEE99; pYI14
ARO1/DG 2-2 30/30 V583 prophage 6 EF2823 terminase, large subunit, putative
Fly1 3-4 30/30 V583 prophage 6 EF2838 DNA replication protein
Fly1 3-5 29/30 V583 pTEF1 EF_A0022-EF_A0024 intergenic region E. faecalis pAM373; pAD1
Fly1 3-6 29/30 V583 prophage 6 EF2825 conserved hypothetical protein
T11 3-6 30/30 V583 pTEF1 EF_A0083 rep-1 E. faecalis pAD1
a The CRISPR locus (1, 2, or 3) followed by the spacer number is shown. CRISPR spacers are numbered in consecutive order from left to right as shown in Fig. 1.
b Sequence identity is shown as the number of base pairs with sequence identity in GenBank/total number of base pairs in spacer.
c V583 variable regions (VR) are from a report by McBride et al. (10).
d This spacer is identical to ATCC 4200 CRISPR2 spacer 5.
e This spacer is identical to ATCC 4200 CRISPR2 spacer 6.
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conserved chromosomal positions: the CRISPR1-cas locus oc-
curred between EF0672 and EF0673 homologues, CRISPR2 be-
tween EF2063 and EF2061 homologues, and CRISPR3-cas be-
tween EF1760 and EF1759 homologues. Based on this
information, we extended the analysis of E. faecalis CRISPR by
examining 29 additional isolates, including strains with isolation
dates prior to the mid-1970s (Fig. 2; for additional isolation date
FIG 2 CRISPR-cas and acquired antibiotic resistance in a historical collection of E. faecalis strains. E. faecalis strains are listed by date of isolation, from oldest
to most recent. Acquired antibiotic resistance is shown in red, and CRISPR-cas presence is shown in green. Antibiotic resistance (tetracycline [tetL and tetM],
erythromycin [ermB], gentamicin [aac6=-aph2==], chloramphenicol [cat], ampicillin [blaZ], and vancomycin [vanA and vanB]) was previously proﬁled (red
squares) (10). A single asterisk indicates that gentamicin resistance is conferred by a 3=-5==-aminoglycoside phosphotransferase in this strain; double asterisks
denote E. faecalis strains for which draft or complete genome sequences are available.
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material).E.faecalisstrainswereﬁrstscreenedforinternalregions
of CRISPR1 csn1 and CRISPR3 csn1 by PCR. Strains negative by
PCR were rescreened with primers annealing outside the con-
served CRISPR1-cas or CRISPR3-cas locus positions, and prod-
ucts from these reactions were sequenced to conﬁrm CRISPR ab-
sence. Using this approach, positive PCR results indicating the
presenceorabsenceofCRISPRwereobtainedforallstrainstested.
CRISPR2 was detected by ampliﬁcation of the conserved locus in
all 29 E. faecalis strains and conﬁrmed by DNA sequencing.
CRISPR content for E. faecalis V583,
OG1RF, and HH22, as previously re-
ported (17, 25), was included in the anal-
ysis.
All 48 E. faecalis strains possess an or-
phan CRISPR2 locus (see Table S1 in the
supplemental material). In contrast,
CRISPR-cas distribution varies among
antibiotic-sensitive and antibiotic-
resistant strains (Fig. 2). One-third of the
E.faecalisstrainsinourcollection(16/48)
possess a complete CRISPR-cas locus
(CRISPR1-cas or CRISPR3-cas), and all
but two of these either lack acquired an-
tibioticresistancegenesorpossesstetM,a
genecommonlydisseminatedbytheself-
mobilizable conjugative transposon
Tn916 (29, 30). Strikingly, of the MDR
E. faecalis strains in this collection (de-
ﬁnedasresistanttotwoormoreantibiot-
ics), all except two lack CRISPR-cas loci
(n  22), including all vancomycin-
resistant strains (n  8) (Fig. 2).
We used a combination of statistical
analyses to evaluate the hypothesis that
E. faecalis strains with CRISPR-cas pos-
sess signiﬁcantly fewer acquired antibi-
otic resistance genes than those lacking
CRISPR-cas. We ﬁrst tallied acquired an-
tibiotic resistance genes for each strain
and performed a one-tailed Wilcoxon
rank sum test to address the null hypoth-
esis that there is no difference in the dis-
tributions of acquired antibiotic resis-
tance genes between strains that possess
CRISPR-cas and strains that lack
CRISPR-cas. Because antibiotic resis-
tance genes are often coacquired on ele-
ments conferring resistance to multiple
antibiotics, we performed the Wilcoxon
rank sum test using progressively stricter
models for coacquisition, in which po-
tentially coacquired genes were counted
as resistance to one antibiotic, instead of
two (see Data Set S1 in the supplemental
material). We found that, irrespective of
themodelused,thenullhypothesiscould
be rejected (P  0.001), indicating that
the distributions of acquired antibiotic
resistance signiﬁcantly differ between
CRISPR-cas-positive and -negative E. faecalis strains. Probability
values did not change for a model in which tetM and ermB, which
can be codisseminated by Tn916 and related elements (30), are
coacquired (P values of 0.0003 if acquired jointly and 0.0004 if
acquiredseparately)(DataSetS1).Ifaac6=-aph2==andblaZare
alsoassumedtobecoacquired,aswassuggestedbythepatterns
of occurrence of antibiotic resistance in 106 E. faecalis strains
(10), the P value increases nominally to 0.0005 (Data Set S1).
Finally, if ermB and vancomycin resistance are assumed to be
coacquired (10), in addition to tetM/ermB and aac6=-aph2==/
FIG3 CRISPR-casdistributionacrosstheE.faecalisMLSTdendrogram.AnMLST-baseddendrogram
of the 48 strains utilized in CRISPR proﬁling was generated using the E. faecalis MLST database (see
Materials and Methods). Strains indicated in red possess CRISPR1-cas, and those in blue possess
CRISPR3-cas. Stars denote strains for which draft or complete genome sequences are available. ST,
sequence type; CC, clonal complex.
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Set S1), remaining highly signiﬁcant. We additionally used a
one-tailed Fisher exact test with a 2  2 contingency table
comparing cooccurrences of CRISPR-cas and antibiotic resis-
tance to address the null hypothesis that CRISPR-cas presence
is unrelated to antibiotic resistance. The P value of 0.007 is
highly signiﬁcant (P  0.01), which led us to reject the null
hypothesis (Data Set S1). The results of these analyses demon-
strate that a statistically signiﬁcant relationship between the
presence or absence of CRISPR-cas and acquired antibiotic re-
sistance exists.
To examine the phylogenetic distribution of CRISPR-cas loci
in E. faecalis, we generated an MLST dendrogram of the strains
used for CRISPR analysis (10) (Fig. 3). CRISPR-cas loci are dis-
continuously distributed across this MLST dendrogram, and
CRISPR-cas distribution varies even between strains of a single
sequence type (e.g., ST21 and ST40 lineages) (Fig. 3). In other
lineages, including ST6 (a CC2 lineage; 6 strains), ST9 (a CC9
lineage; 4 strains), and CC8 (8 strains) lineages, CRISPR-cas loci
are uniformly absent. All three lineages are associated with MDR
(9, 10); vancomycin resistance and -lactamase production ﬁrst
emerged in the United States in ST6 strains of CC2 (10), and the
CC2 and CC9 lineages are highly associated with nosocomial in-
fections and hospital endemicity (9). Loss of CRISPR-cas in
founders of these lineages may have precipitated their success in
acquiring traits facilitating hospital adaptation.
CRISPR-cas in E. faecium. No CRISPR loci were identiﬁed
in seven recently reported E. faecium draft genomes (31). We
therefore examined the CRISPR locus content in eight addi-
tional E. faecium genomes (26). The E. faecium strains origi-
nated from human clinical samples (strains represented by
numbers in Fig. 4 and 5) and from the feces of healthy human
volunteers (Com12 and Com15). All were isolated in the
early to mid-2000s. We identiﬁed an E. faecium CRISPR-cas
locus (EfmCRISPR1-cas) in three genomes (Fig. 4). This
locus is found between homologues of EfaeDRAFT_1858
and EfaeDRAFT_1857 from the previously sequenced clinical
isolate E. faecium DO draft genome (GenBank accession
no. ACIY00000000), which itself lacks CRISPR (25). EfmCRISPR1-
cas possesses a palindromic repeat sequence that is divergent
from those of the E. faecalis CRISPR-cas loci (see Fig. S1 in the
supplementalmaterial).ThefourpredictedCasproteinsencoded
by EfmCRISPR1-cas are consistent with the Nmeni subtype
(Table S4). However, EfmCRISPR-cas differs from the E. faecalis
NmenisubtypebythepresenceofanORFofunknownfunction5=
tothecsn1genewhichisconservedanduniquetothethreestrains
possessing EfmCRISPR-cas (Fig. 4). A Blastn comparison of the
20EfmCRISPR1-casspacerstosequencesintheNCBInonredun-
dantnucleotidedatabaserevealsidentitybetweentwospacersand
previously identiﬁed clostridial and lactococcal phages (Table 2).
MLST phylogeny and acquired antibiotic resistance proﬁles
were determined for the eight E. faecium strains. Four strains be-
long to the hospital-adapted CC17, being either ST17 or double-
locus variants of ST17 (Fig. 5; see Table S5 in the supplemental
material).AsexpectedforCC17strains(1),allareMDR.Threeof
the CC17 strains possess vanA, encoding vancomycin resistance,
while the fourth CC17 strain constitutes a novel sequence type
variantandlacksvanA.Theremainingfourstrainsbelongtoother
sequence types and lack acquired antibiotic resistance genes
(Fig. 5). Although the E. faecium analysis was smaller in sample
size than that for E. faecalis, the distribution of EfmCRISPR1-cas
inthesegenomessupportstheconclusionthatMDRenterococcal
strains generally lack CRISPR-cas; in this case, three of four MDR
strains lack EfmCRISPR1-cas, and these three strains are
vancomycin-resistantmembersofthehospital-adaptedCC17lin-
eage.
MechanismforCRISPR-casvariability.Itwaspreviouslypro-
posedthatdeletionofaStreptococcusthermophilusNmenisubtype
CRISPR-cas may occur through recombination (32). Nmeni sub-
type CRISPR-cas loci possess a conserved but imperfect CRISPR
repeat upstream of the cas operon, meaning that a Nmeni
CRISPR-cas locus is ﬂanked on both the 5= and 3= ends by repet-
itive sequences (28, 32). It is possible that recombination could
occur at these sites, resulting in deletion (32). We analyzed the
E. faecalis genome sequences corresponding to the locations
where deletion of CRISPR1-cas or CRISPR3-cas would have oc-
curred. Interestingly, E. faecalis strains lacking CRISPR-cas pos-
sess small, common sequences at these sites. E. faecalis V583 pos-
sesses205bpofuniquesequencewhenalignedwiththeE.faecalis
D6 CRISPR1-cas and ﬂanking region and 53 bp of unique se-
quence compared to the Fly1 CRISPR3-cas region (Fig. 1). These
205-bp and 53-bp sequences are highly conserved in all E. faecalis
FIG 4 EfmCRISPR1-cas loci in E. faecium draft genomes. Homologues of
E.faeciumDOgenesareshownasgreyarrowsandwithDOORFassignments.
EfmCRISPR1-caslocus-speciﬁcgenesareshownaswhitearrows,andCRISPR
spacers are represented by black diamonds. CRISPR spacers with identity to
mobile elements are starred. Note that CRISPR repeats are not shown. The
ﬁgure is not drawn to scale.
TABLE 2
E. faecium EfmCRISPR1-cas spacer identities to mobile genetic elements
Strain Spacera
Sequence
identityb
Representative
BLASTN hit
Area of
homology
1,231,408 3 28/30 Clostridium novyi NT genome NT01CX_2197, putative phage antirepressor
1,231,408 6 28/30 Lactococcus lactis subsp. lactis KF147 genome LLKF_1066, phage protein, HNH endonuclease
a CRISPR spacers are numbered in consecutive order from left to right as shown in Fig. 4.
b Sequence identity is shown as the number of base pairs with sequence identity in GenBank/total number of base pairs in spacer.
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the supplemental material). This would not be predicted for
CRISPR-cas loss by homologous recombination and excision.
Werecentlyreportedthelow-frequencymobilizationandcon-
jugal transfer of large regions of chromosomal DNA from E. fae-
calis V583 donors to E. faecalis OG1RF recipients, resulting in
transconjugant strains with hybrid V583-OG1RF genomes (33).
This transfer was found to be dependent on either of two
pheromone-responsive plasmids resident in V583, pTEF1 or
pTEF2, and occurred as the result of plasmid integration and
chromosome mobilization. Chromosome-to-chromosome
movement of the PAI, a vancomycin resistance transposon, cap-
sule genes, and other V583 genes to OG1RF recipients was ob-
served. It is important to note that OG1RF does not possess
CRISPR spacers with identity to pTEF1, pTEF2, or other V583
sequences (17), and in these experiments, CRISPR1-cas did not
block incoming DNA from V583. Because the OG1RF CRISPR1-
caslocusoccurs~41.5kb3=tothesiteofPAIincorporation,itwas
of interest to determine whether the CRISPR1-cas locus in PAI-
containingtransconjugantshadbeendisplacedbyincomingDNA
from V583 donors. We used ﬁve strains (TC1, TC3, TC4, TC5,
andTC12)representingtheﬁveclassesofPAItransconjugants(A
toE)identiﬁedinourpreviousstudy(33).Thesetransconjugants
possesstheV583PAIandvariousamountsofﬂankingDNA,rep-
resenting a total acquisition of 285 to 857 kb of V583 donor chro-
mosome (33). The ﬁve PAI-containing transconjugants were
screened for the occurrence of the OG1RF CRISPR1-cas by PCR.
Strikingly, all ﬁve transconjugants lacked CRISPR1-cas and in-
steadpossessedatthislocustheconserved205-bpsequencefound
in the V583 donor (see Fig. S2 in the supplemental material).
Thus, in a single conjugative transfer event, a novel hybrid strain
that simultaneously becomes antibiotic resistant, acquires the
PAI, and is rendered deﬁcient for CRISPR-cas can be generated.
DISCUSSION
Weexamined48E.faecalisstrainsfromahistoricalcollectionand
8 recent E. faecium isolates to determine the relationship between
CRISPR and the emergence of multidrug resistance in entero-
cocci.WefoundthatCRISPR1-casandCRISPR3-caslociarevari-
able among E. faecalis strains, but, interestingly, an orphan
CRISPR2 locus occurred in all E. faecalis strains tested. Selective
pressure for maintenance of CRISPR2 in a CRISPR-cas-deﬁcient
E. faecalis background is unclear, as is the origin of CRISPR2 (i.e.,
whether this locus is functionally and evolutionarily linked to
CRISPR1-cas,oronceindependentlypossessedcasgenesthathave
been lost). CRISPR1-cas and CRISPR2
repeat sequences are identical (17), and
because Cas proteins interact with
CRISPRrepeatsequencesfollowingtran-
scription (22), it is likely that CRISPR1-
cas and CRISPR2 are functionally linked.
Nevertheless, genome sequence analysis
ﬁnds that CRISPR-cas-deﬁcient E. faeca-
lisstrainslackanydetectablecsn1orcsn1-
likegene,whichisessentialforprotection
mediated by a Nmeni subtype CRISPR-
cas locus (20). The lack of required func-
tional genes in strains with the CRISPR2
orphan locus, together with the abun-
dance of antibiotic resistance genes in
these strains, indicates that CRISPR2 alone does not confer im-
munity in E. faecalis hosts. Ultimately, a functional analysis of the
CRISPR1-cas and CRISPR2 loci will be required to conﬁrm this
hypothesis.
By analyzing a large data set, we were able to detect identities
between CRISPR spacers and sequences on known mobile ele-
ments,includingpheromone-responsiveplasmidsandphage.En-
terococci have a highly coevolved relationship with the narrow-
host-range pheromone-responsive plasmids, which encode
machinery to utilize extracellular signals produced by enterococ-
calcellstoinduceconjugationfunctionsandtomanipulatesignal
production in enterococcal cells in which they reside (34). The
results of this study and our recent work (33) support a role for
pheromone-responsive plasmids as important drivers of entero-
coccalgenomeplasticity,capableofpromotingtheirowntransfer,
mobilizing chromosomally encoded antibiotic resistance and vir-
ulence determinants, and now also causing displacement of
CRISPR-cas.
That E. faecalis CRISPR loci contain spacers with identity to
enterococcal mobile elements, and the distribution of these spac-
ers,suggeststhatcertainelements,suchaspheromone-responsive
plasmids, are frequently encountered by E. faecalis and/or have a
propensity to be incorporated into CRISPR loci as spacers. It is
interesting that no CRISPR spacers have yet been identiﬁed with
sequence identity to conjugative transposons such as Tn916,
which are also vectors of antibiotic resistance in the enterococci
(29).CRISPRelementshavebeenshownexperimentallytoconfer
immunitytoplasmidsandphages(20–23),althoughmanymech-
anistic details remain unknown. To our knowledge, there is no
experimental evidence that CRISPR defense confers protection
from conjugative transposons. The observation that the tetM
gene, commonly disseminated by Tn916 and related conjugative
transposons (29, 30), is present in E. faecalis strains possessing
CRISPR-cas (Fig. 2) suggests that conjugative transposons may
evade this defense. Spacers targeting the Inc18 plasmid family,
plasmids that are signiﬁcant for their role in the dissemination of
vancomycinresistancegenesfromenterococcitoMRSA(6,7),are
also absent. Tn916 and the Inc18 plasmid family are broad host
range in nature (29, 30), and the notable lack of spacers with
identity to these elements may reﬂect the relative rarity of inter-
species transfer or the relative inefﬁciency of transfer of elements
lacking mechanisms for effective pair formation, such as the
pheromone-induced aggregation mechanism.
Of the 48 E. faecalis and 8 E. faecium strains examined in this
study,7E.faecalisand2E.faeciumstrainslackedCRISPR-casand
FIG 5 MLST, EfmCRISPR1-cas, and acquired antibiotic resistance in E. faecium draft genomes.
Acquired antibiotic resistance is shown in red, and CRISPR-cas presence is shown in green. Antibiotic
resistance (tetracycline [tetM], erythromycin [ermB], gentamicin [aac6=-aph2==], and vancomycin
[vanA]), EfmCRISPR1-cas, and ST proﬁles were generated by genomic analysis.
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September/October 2010 Volume 1 Issue 4 e00227-10 mbio.asm.org 7also lacked antibiotic resistance. Draft genome sequences are not
available for six of these nine strains, so it remains a formal possi-
bility that novel CRISPR-cas loci may be found in those strains.
Alternatively, it may be that the absence of CRISPR-cas (particu-
larly in strains isolated before, or early in, the age of antibiotics,
such as E. faecalis D173 [isolated in 1939], ATCC 19433 [isolated
before1942],andT1[isolatedbefore1950][10])facilitatedacqui-
sition of a mobile element carrying traits other than antibiotic
resistance (for example, hemolysin/bacteriocin production and
resistance or new metabolic properties), which provided a selec-
tive advantage.
Mobile elements often provide an accessory pool of genes that
enhance survival in select environments. It is possible that ele-
ments such as the pheromone-responsive plasmids and putative
enterococcalself-defensemechanismssuchasCRISPR-casact,re-
spectively, to diversify and to stabilize the enterococcal genome,
and that the dynamic between these opposing forces is important
for the ultimate success of these microbes. Based on the data pre-
sented here, we speculate that modern antibiotic therapy has
shifted this dynamic toward the facile acquisition of foreign ele-
ments conferring antibiotic resistance, among other things, de-
creasing genome stability/increasing plasticity, and enabling the
colonization of new habitats, including the antibiotic-laden hos-
pital environment.
MATERIALS AND METHODS
Genomes, bacterial strains, and media. Draft genome data for 16 E. fae-
calis and 8 E. faecium strains were generated in collaboration with
the Broad Institute (26) and accessed at the Enterococcus database web-
site (http://www.broadinstitute.org/annotation/genome/enterococcus
_faecalis/MultiHome.html). E. faecalis strains used for CRISPR proﬁling
are shown in Fig. 2 and in Data Set S1 in the supplemental material and
have previously been described with respect to isolation dates, antibiotic
resistance proﬁles, and MLST data (10). E. faecalis OG1RF transconju-
gants TC1, TC3, TC4, TC5, and TC12, which received the PAI and other
chromosomalmarkersfromE.faecalisV583inconjugativetransfers,have
been previously described (33). E. faecalis was routinely cultured at 37°C
on brain heart infusion (BHI) agar.
CRISPR locus identiﬁcation in draft genome sequences. CRISPR
loci were identiﬁed in 16 E. faecalis and 8 E. faecium draft genomes (26)
using CRISPRﬁnder (http://crispr.u-psud.fr/Server/CRISPRﬁnder.php)
(27). Sequence data from the Broad Institute Enterococcus database were
downloaded, and CRISPR repeat-spacer arrays were manually annotated
in MacVector to conﬁrm the presence of CRISPR. In E. faecalis strains
Fly1,HIP11704,andT2,theCRISPR2locuswasdetectedbyannotationof
the intergenic region between homologues of the E. faecalis V583 ORFs
EF2063 and EF2061 and not by CRISPRﬁnder. Conserved domains in
putative CRISPR3 and EfmCRISPR1 Cas proteins were identiﬁed by
Blastp of the NCBI nonredundant protein database. CRISPR spacer se-
quences were compared to GenBank sequences using Blastn of the NCBI
nonredundant nucleotide database with default parameters for short in-
put sequences. Sequence alignments were generated with ClustalW in
MacVector.
CRISPR locus screening by PCR. Locations of screening primers
used in this study relative to CRISPR locus positions are shown in
Fig.1.Twenty-nineE.faecalisstrainswerescreenedforCRISPRlociby
colonyPCR.Coloniesweresuspendedin25lTris-EDTA(TE)buffer,
boiledat98to100°Cfor5min,andpelletedbycentrifugation,and2l
supernatantwasusedasthetemplateperstandardPCRwithTaqpoly-
merase(NewEnglandBiolabs).Primersamplifyinga676-bpregionof
the 16S-B rRNA gene (For-5=-CAT GCA AGT CGA ACG CTT CT-3=,
Rev-5=-CCATATATCTACGCATTTCAC-3=)wereusedinpositive-
control reactions for each colony lysate. To screen for CRISPR1-cas
loci, primers amplifying a 783-bp internal region of the E. faecalis D6
CRISPR1-cas csn1 homologue EFLG_01963 (For-5=-CAG AAG ACT
ATC AGT TGG TG-3=, Rev-5=-CCT TCT AAA TCT TCT TCA TAG-
3=) were used. To screen for CRISPR3-cas loci, primers amplifying a
258-bp internal region of the E. faecalis Fly1 CRISPR3-cas csn1 homo-
logue EFKG_00787 (For-5=-GCT GAA TCT GTG AAG TTA CTC-3=,
Rev-5=-CTGTTTTGTTCACCGTTGGAT-3=)wereused.Toidentify
CRISPR2 loci, primers nested in EF2063 and EF2061 homologues
ﬂankingtheE.faecalisMerz96CRISPR2locus(For-5=-CTGGCTCGC
TGT TAC AGC T-3=, Rev-5=-GCC AAT GTT ACA ATA TCA AAC
A-3=)wereused.CRISPR2productsweresubmittedforDNAsequenc-
ing at the Massachusetts General Hospital DNA Sequencing Core Fa-
cility,andCRISPR2lociweremanuallyannotatedinMacVectorforall
29 E. faecalis strains.
Because divergence of csn1 genes may have led to false-negative PCR
results, E. faecalis strains with negative PCR results were further screened
with primers ﬂanking the conserved locations of the CRISPR1-cas and
CRISPR3-cas loci, between homologues of EF0672-EF0673 and EF1760-
EF1759,respectively.ColonyPCRwasperformedasdescribedabovewith
primer pairs ﬂanking the E. faecalis CRISPR1-cas region (For-5=-GCG
ATG TTA GCT GAT ACA AC-3= and Rev-5=-CGA ATA TGC CTG TGG
TGAAA-3=;expectedproductsizeof315bpforstrainslackingCRISPR1-
cas) and ﬂanking the E. faecalis CRISPR3-cas region (For-5=-GAT CAC
TAG GTT CAG TTA TTT C-3= and Rev-5=-CAT CGA TTC ATT ATT
CCT CCA A-3=; expected product size of 224 bp for strains lacking
CRISPR3-cas). E. faecalis strains for which CRISPR-cas loci were not de-
tected in genomic analyses (Fig. 1) were similarly screened. E. faecalis
OG1RF, Fly1, and V583 were included as positive and negative controls
where appropriate. All PCR products were sequenced to conﬁrm the ab-
sence of CRISPR loci.
E. faecalis OG1RF transconjugants were screened for the presence of
CRISPR1-cas (33) by PCR using a primer nested in EF0672 (For-5=-GCG
ATG TTA GCT GAT ACA AC-3=) and a primer nested in CRISPR1-cas
csn1(Rev-5=-CTTCACCAACTGATAGTCTTC-3=).E.faecalisOG1RF
wasincludedasapositivecontrol.Strainswereadditionallyscreenedwith
CRISPR1-cas ﬂanking primers as described above, and products were
sequenced to conﬁrm the absence of CRISPR1-cas.
Analysis of E. faecalis CRISPR distribution. To test whether the ac-
quired antibiotic resistance gene contents of CRISPR-cas-positive and
-negativestrainssigniﬁcantlydiffered,datawereanalyzedbythenonpara-
metric Wilcoxon rank sum test and the Fisher exact test. MLST data for
E.faecalisstrainshavebeenpreviouslyreported(10),andanMLST-based
phylogenetic tree of strains used in this study was generated using the
E. faecalis MLST database (http://efaecalis.mlst.net/).
Analysis of E. faecium genomes. MLST of E. faecium strains was per-
formed by concatenating sequences of the adk, atpA, ddl, gdh, gyd, purK,
andptsSallelesforeachstrainandcomparingthemtoknownsequencesin
the E. faecium MLST database (35) (http://efaecium.mlst.net/). Single-
and double-locus variants of ST17 were assigned to the CC17 lineage.
Antibiotic resistance genes were identiﬁed by Blastp queries of the Broad
Institute Enterococcus group database with reference enterococcal resis-
tance proteins from the NCBI protein database. Accession numbers for
the proteins used in the Blastp queries are as follows: for TetM (Entero-
coccus faecium), accession no. ADA62733; TetL (Enterococcus faecium),
AAL92527;VanA(Enterococcusfaecium),ACC93633;VanB(Enterococcus
faecium), AAQ12894; ErmB (Enterococcus faecium), AAF86219; Cat (En-
terococcus faecium), AAF64429; BlaZ (Enterococcus faecalis HH22),
AAA24777; and Aac6=-Aph2==, P0A0C2. Genes encoding VanB, Cat, and
BlaZ were not detected in draft E. faecium genomes in this database.
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